These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1503679

  • 21. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
    Verbelen M, Lewis CM.
    Pharmacogenomics; 2015; 16(9):915-7. PubMed ID: 26122865
    [No Abstract] [Full Text] [Related]

  • 22. Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.
    Verbelen M, Collier DA, Cohen D, MacCabe JH, Lewis CM.
    Pharmacogenomics J; 2015 Oct; 15(5):461-6. PubMed ID: 25732907
    [Abstract] [Full Text] [Related]

  • 23. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [Abstract] [Full Text] [Related]

  • 24. Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population.
    Saito T, Ikeda M, Mushiroda T, Ozeki T, Kondo K, Shimasaki A, Kawase K, Hashimoto S, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Takeda M, Kamatani Y, Numata S, Ohmori T, Ueno S, Makinodan M, Nishihata Y, Kubota M, Kimura T, Kanahara N, Hashimoto N, Fujita K, Nemoto K, Fukao T, Suwa T, Noda T, Yada Y, Takaki M, Kida N, Otsuru T, Murakami M, Takahashi A, Kubo M, Hashimoto R, Iwata N.
    Biol Psychiatry; 2016 Oct 15; 80(8):636-42. PubMed ID: 26876947
    [Abstract] [Full Text] [Related]

  • 25. HLA-associations in Leponex/Clozaril (clozapine)-induced granulocytopenia and agranulocytosis. Statistical viewpoints.
    Abt K, Gülich A, Krupp P, Reinberg W.
    Drug Saf; 1992 Oct 15; 7 Suppl 1():10-6. PubMed ID: 1503672
    [Abstract] [Full Text] [Related]

  • 26. Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine.
    Anıl Yağcioğlu AE, Yoca G, Ayhan Y, Karaca RÖ, Çevik L, Müderrisoğlu A, Göktaş MT, Eni N, Yazıcı MK, Bozkurt A, Babaoğlu MO, Clozapine-Associated LeukopeniaAgranulocytosis Study Group.
    J Clin Psychopharmacol; 2016 Jun 15; 36(3):257-61. PubMed ID: 27043126
    [Abstract] [Full Text] [Related]

  • 27. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
    McKnight C, Guirgis H, Votolato N.
    Am J Psychiatry; 2011 Oct 15; 168(10):1120. PubMed ID: 21969051
    [No Abstract] [Full Text] [Related]

  • 28. Clozapine-induced agranulocytosis and its genetic determinants.
    Opgen-Rhein C, Dettling M.
    Pharmacogenomics; 2008 Aug 15; 9(8):1101-11. PubMed ID: 18681784
    [Abstract] [Full Text] [Related]

  • 29. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.
    Amar A, Segman RH, Shtrussberg S, Sherman L, Safirman C, Lerer B, Brautbar C.
    Int J Neuropsychopharmacol; 1998 Jul 15; 1(1):41-44. PubMed ID: 11281944
    [Abstract] [Full Text] [Related]

  • 30. Clozapine induced agranulocytosis: hypothesis on immune-mediated pathogenesis and the role of haematopoietic growth factors.
    Faber HJ, Smit AJ, van de Loosdrecht AA.
    Neth J Med; 1999 Aug 15; 55(2):86-7. PubMed ID: 10474279
    [No Abstract] [Full Text] [Related]

  • 31. NQO2 gene is associated with clozapine-induced agranulocytosis.
    Ostrousky O, Meged S, Loewenthal R, Valevski A, Weizman A, Carp H, Gazit E.
    Tissue Antigens; 2003 Dec 15; 62(6):483-91. PubMed ID: 14617031
    [Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.
    Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J.
    Pharmacogenomics J; 2019 Apr 15; 19(2):211-218. PubMed ID: 29298994
    [Abstract] [Full Text] [Related]

  • 33. Genetic factors in clozapine-induced agranulocytosis.
    Reznik I, Mester R.
    Isr Med Assoc J; 2000 Nov 15; 2(11):857-8. PubMed ID: 11344758
    [No Abstract] [Full Text] [Related]

  • 34. Mechanisms of clozapine-induced agranulocytosis.
    Gerson SL, Meltzer H.
    Drug Saf; 1992 Nov 15; 7 Suppl 1():17-25. PubMed ID: 1503673
    [Abstract] [Full Text] [Related]

  • 35. HLA typing costs.
    Landy DA.
    J Clin Psychiatry; 1993 Jun 15; 54(6):236-7. PubMed ID: 8331095
    [No Abstract] [Full Text] [Related]

  • 36. More than 25 years of genetic studies of clozapine-induced agranulocytosis.
    de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA.
    Pharmacogenomics J; 2017 Jul 15; 17(4):304-311. PubMed ID: 28418011
    [Abstract] [Full Text] [Related]

  • 37. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
    Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, Howard A.
    J Clin Psychiatry; 1988 Jul 15; 49(7):271-7. PubMed ID: 3391979
    [Abstract] [Full Text] [Related]

  • 38. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May 15; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 39. Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis.
    Hasegawa M, Cola PA, Meltzer HY.
    Neuropsychopharmacology; 1994 Aug 15; 11(1):45-7. PubMed ID: 7945743
    [Abstract] [Full Text] [Related]

  • 40. Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?
    Mosyagin I, Cascorbi I, Schaub R, Krüger T, Dettling M.
    J Clin Psychopharmacol; 2005 Oct 15; 25(5):435-40. PubMed ID: 16160618
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.